Indivior PLC, a revenue-generating company in the opioid dependence market, is trading near 52-week lows despite strong financials and solid prospects. The company faces competition, especially from ...

Indivior shares sold off on July 9th due to unexpected negative news from management, including the discontinuation of the schizophrenia drug Perseris and lower Sublocade guidance. Below, I argue why ...

Expects slower near term growth for Sublocade Sublocade sales impacted by rapid adoption of Camurus' Brixadi Shares fell as much as 21.5%, lowest since 2021 Oct 10 (Reuters) - British drugmaker ...